Evaluation of the Renal Function Using Cystatin C Level in the Patients Receiving Cisplatin-Based Chemotherapy

References

• Patterson WP, Reams GP. Renal toxicities of chemotherapy. Semin Oncol. 1992;19:521–528.
   PubMed Web of Science ®Google Scholar
• Weiss RB. Nephrotoxicity. In: DeVita VT, Hellman S, Rosenberg SA, eds. Principles and Practice of Oncology. Philadelphia: Lippincott-Raven Press; 1997:2796–2800.
   Google Scholar
• Mohanram A, Toto R. Measurement of kidney function. In: Pereira BJG, Sayegh MH, Blake PG, eds. Chronic Kidney Disease, Dialysis, and Transplantation. A Companion to Brenner and Rector's the Kidney. Philadelphia: Saunders; 2005:20–30.
   Google Scholar
• Perrone RD, Madias NE, Levy AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992;38:1933–1953.
   PubMed Web of Science ®Google Scholar
• Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985;28:830–838.
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1990;130:461–470.
   Google Scholar
• Hergeth-Rosenthal S, Trabold S, Pietruck F, Holtmann M, Philipp T, Kribben A. Cystatin C: efficacy as screening test for reduced glomerular filtration rate. Am J Nephrol. 2000;20:97–102.
   PubMed Web of Science ®Google Scholar
• Stabuc B, Vrhovec L, Stabuc-Silih M, Cizej TE. Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy. Clin Chem. 2000;46:193–197.
   PubMed Web of Science ®Google Scholar
• Benohr P, Grenz A, Hartmann JT, Müller GA, Blaschke S. Cystatin C—A marker for assessment of the glomerular filtration rate in patients with cisplatin chemotherapy. Kidney Blood Press Res. 2006;29:32–35.
   PubMed Web of Science ®Google Scholar
• Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol. 1992;38:20–27.
   PubMed Web of Science ®Google Scholar
• Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A. Cystatin C as a marker of GFR—History, indications, and future research. Clin Biochem. 2005;38:1–8.
   PubMed Web of Science ®Google Scholar
• Risch L, Herklotz R, Blumberg A, Huber AR. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem. 2001;47:2055–2059.
   PubMed Web of Science ®Google Scholar
• Manetti L, Pardini E, Genovesi M, et al. Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest. 2005;28:346–349.
   PubMed Web of Science ®Google Scholar
• Bökenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C—A new marker of glomerular filtration rate in children independent of age and height. Pediatrics. 1998;101:875–881.
   PubMed Web of Science ®Google Scholar
• Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40:221–226.
   PubMed Web of Science ®Google Scholar
• Bárdi E, Bobok I, Oláh AV, Oláh É, Kappelmayer J, Kiss C. Cystatin C is a suitable marker of glomerular function in children with cancer. Pediatr Nephrol. 2004;19:1145–1147.
   PubMed Web of Science ®Google Scholar
• Bölke E, Schieren G, Gripp S, et al. Cystatin C—A fast and reliable biomarker for glomerular filtration rate in head and neck cancer patients. Strahlenther Onkol. 2011;187:191–201.
   PubMed Web of Science ®Google Scholar
• Grönroos MH, Jahnukainen T, Irjala K, et al. Comparison of glomerular function tests in children with cancer. Pediatr Nephrol. 2008;23:797–803.
   PubMed Web of Science ®Google Scholar
• Yano M, Hirai K, Naito Z, et al. Expression of cathepsin B and cystatin C in human breast cancer. Surg Today. 2001;31:385–389.
   PubMed Web of Science ®Google Scholar
• Kos J, Werle T, Lah T, Brunner N. Cysteine proteinases and their inhibitors in extracellular fluids: marker for diagnosis and prognosis in cancer. Int J Biol Markers. 2000;15:84–89.
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470.
   PubMed Web of Science ®Google Scholar
• Lankisch P, Wessalowski R, Maisonneuve P, Haghgu M, Hermsen D, Kramm CM. Serum cystatin C is a suitable marker for routine monitoring of renal function in pediatric cancer patients, especially of very young age. Pediatr Blood Cancer. 2006;46:767–772.
   PubMed Web of Science ®Google Scholar
• Bodnar L, Wcislo GB, Smoter M, et al. Cystatin C as a parameter of glomerular filtration rate in patients with ovarian cancer. Kidney Blood Press Res. 2010;33:360–367.
   PubMed Web of Science ®Google Scholar
• Kos J, Krasovec M, Cimerman N, Nielsen HJ, Christensen IJ, Brünner N. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin Cancer Res. 2000;6:505–511.
   PubMed Web of Science ®Google Scholar
• Strojan P, Svetic B, Smid L, Kos J. Serum cystatin C in patients with head and neck carcinoma. Clin Chim Acta. 2004;344:155–161.
   PubMed Web of Science ®Google Scholar
• Tumminello FM, Flandina C, Crescimanno M, Leto G. Circulating cathepsin K and cystatin C in patients with cancer-related bone disease: clinical and therapeutic implications. Biomed Pharmacother. 2008;62:130–135.
   PubMed Web of Science ®Google Scholar